(Date:9/4/2008)... may be shortchanging their golden years by tappin...iversity of Illinois expert who has studied the fe..., More than three of every four Americans trim th...iming benefits early, a choice many might forego i... consequences, law professor Richard L. Kaplan say...
(Date:9/4/2008)...ncology contract research organization, has publis...uanced Approach to Get Into the Clinic Faster.&quo...al research scientist with 35 years of experience,...mmonly viewed as straightforward investigations ru...rue integration with preclinical, regulatory and c...
(Date:9/4/2008)...NORWICH, England and ONGAR, Ireland,Sept. 4 /PRNe...ofield Media,Europe Ltd, announced on the 29th Aug... publication from Silverdog Publishing., Health a... the iconic,Health and Safety at Work Act 1974 and.... It has been relied upon by blue-chip corporates,...
(Date:9/4/2008)...-FirstCall/ -- ULURU Inc. (Amex:,ULU) today announ...Weisel,Partners Healthcare Conference at 3:15 p.m....out ULURU Inc.:, ULURU Inc. is an emerging specia...ent of a portfolio of wound management, plastic su...nd consumers improved clinical,outcomes through co...
Breaking Medicine News(10 mins):Health News:New guide explores making the most of Social Security 2Health News:New guide explores making the most of Social Security 3Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 2Health News:Oncology Clinical Research Scientist Recommends a Nuanced Preclinical Study Process to Speed Drug Development 3Health News:Schofield Publishing Enters the Newsletter Market 2...ed in the prestigious international journal 'The L...ealth Research (MSHR) in Darwin// has revealed a b...ease which effects 40 per cent of the worlds popul...alaria effecting humans, P. vivax and P. falciparu...
...dical specialists have left for Pakistan to partic...ts, infertility, menopause// , medical education, ...in the South Asian region. Federation of Obstetr...f India (FOGSI) chief Narendra Malhotra has left f...
...ves Women's Day to celebrate the emancipation and ...l reason to rejoice//. In addition to the distinct... laurel of becoming Nepal's only graduate goddess....shmila, now 24, was worshipped and revered through...
...dialysis patients found that nearly 70 percent had...redictor of cardiovascular disease// , at the time...tion further illuminates the relationship between ...is patients are already known to have an elevated ...
Other Medicine News:Health News:Researchers Discover Breakthrough in Malaria Treatment 2Health News:Nepal Gets Its First Graduate Goddess 2(Date:9/4/2008)... September 4 /- Axentis Pharma AG has...e safety and tolerability,of a new therapeutic for...ection in cystic fibrosis patients. The new formul...e delivered directly to the site of,infection. The...f two,different doses of the new drug. Initial res...
(Date:9/4/2008)...atient Identification for Targeted Therapies ...ment HUNTINGTON BEACH, Calif., and AMSTERDAM, N...ld leader in molecular cancer diagnostics,today a...ostic test that,allows physicians to quantitativel...ogen receptor (ER), progesterone receptor (PR) and...
(Date:9/3/2008)...ion Asked. Wrong Children Studied. Wrong,Conclusio...swire/ -- A Centers for Disease,Control and Preven... link,between the MMR vaccine and autism. The Nati... nothing to dispel the growing public concern over...estions concerning design,and methodology., For y...
(Date:9/3/2008)...p results from chronically infected Hepatitis C,pa...btained earlier in 2008, - Study is the first to... antiviral effect of therapeutic Hepatitis C v...port move into a second generation, vaccine formu...ough TLR activation,...
Breaking Medicine Technology:Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 2Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 3Cystic Fibrosis Axentis Pharma Initiates Clinical Trial for Lung Infections 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2CDC Misses Target With Flawed MMR/Autism Study 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 2Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 3Favourable Six Months Follow-Up Results From Intercell's Phase II Therapeutic Hepatitis C Program 4Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 947 1Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 947 2Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 947 3Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 947 4Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 947 5Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration 947 6Statement by MITA Vice President Andrew Whitman on the Benefits of CT Scans Relative to Radiation Dose Risks 7253 1Statement by MITA Vice President Andrew Whitman on the Benefits of CT Scans Relative to Radiation Dose Risks 7253 2MEDEX 360m Rates the State of Global Medical Care for Travelers 7248 1MEDEX 360m Rates the State of Global Medical Care for Travelers 7248 2Bavarian Nordic Reports Positive Data from First EUA Enabling Study with IMVAMUNE 28R 29 Smallpox Vaccine Candidate 7243 1Bavarian Nordic Reports Positive Data from First EUA Enabling Study with IMVAMUNE 28R 29 Smallpox Vaccine Candidate 7243 2... the 11th International Myeloma Workshop -, NORTH .../PRNewswire/ -- The International Myeloma Foundati...ation, advocacy and support,for myeloma patients, ... that updated statistics reported at the 11th Inte...mproved survival for a wide,range of myeloma patie...
...and KOS, Greece, June 29, 2007 /PRNewswire/ --,The... for,previously treated patients on REVLIMID (lena...ian survival of 35 months, nearly,three years. The...led Phase III trials that enrolled more than 700 p...These updated results,were presented at the 11th I...
Other Medicine Technology:The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 2The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 3The International Myeloma Foundation Says Data Reported at a Global,Medical Meeting in Greece Demonstrates Improved Survival for a Wide,Range of Myeloma Patients 4The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2...vailable at manufacturer-direct prices. We set th...g superior quality withunmatched customer support....rt, SheerVision loupes are the clear choice for me...pes come compete with clear lens covers, fully-lin...
...ers superior illumination in a lightweight, go-any...powerful, long-lasting illumination with unrestric.... High center-beam brightness and hands-free opera...rechargeable battery provides over five hours of u...
Easy pull-on garment's feature Rainey's exclusive Non-Slip Domedesign and adjustable Velcro© closure at neck for optimal comfort and support. Choose covered or non covered ear design.
A CDI original design with seams on the outside, away from the skin, adjustable fit and removable/adjustable back strap, provides patient comfort and needed compression.
Medicine Products: